Author:
Li Lei,Sun Meijun,Sun Jianping,Kong Hangru,Zhong Wenwen,Wang Hong
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism
Reference39 articles.
1. Gallagher JC (1990) The pathogenesis of osteoporosis. Bone Mineral 9(3):215–227.
https://doi.org/10.1016/0169-6009(90)90039-I
2. National Health Commission of the People’s Republic of China (2018) The epidemiological investigation of osteoporosis in China.
http://www.nhc.gov.cn/wjw/zcjd/201810/4988546cfa1040db86c1815d3dad7a2b.shtml
. Accessed 20 Oct 2018
3. Cauley JA, Zmuda JM, Ensrud KE, Bauer DC, Ettinger B (2001) Timing of estrogen replacement therapy for optimal osteoporosis prevention. J Clin Endocrinol Metab 86(12):5700–5705.
https://doi.org/10.1210/jcem.86.12.8079
4. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial. JAMA 288(3):321–333.
https://doi.org/10.1001/jama.288.3.321
5. Ghanem K (2007) Beneficial effects of soybean protein and isoflavone extract supplementation on bone density and plasma lipids in females rats. Pol J Food Nutr Sci 57(1):103–108
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献